Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-01-15 | 2021-02-11 | 131694 |
| TEVA-GABAPENTIN | 800MG | TABLET | Avoided shortage | 2025-01-30 | 2025-03-13 | 249201 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2021-03-18 | 2021-04-21 | 135965 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118915 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2020-04-02 | 2020-05-01 | 110694 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183422 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-08-03 | 2023-10-04 | 200910 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-05-29 | 2020-07-09 | 116165 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-20 | 229233 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 198960 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42613 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2019-07-02 | 2020-07-23 | 88164 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-06-27 | 2024-09-12 | 231424 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2025-06-05 | 2025-06-27 | 259688 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Actual shortage | 2026-01-15 | 2026-01-15 | 276239 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167244 |
| TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2025-05-22 | 2025-06-27 | 258121 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| IRINOTECAN FOR INJECTION | 20MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258762 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258481 |
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258717 |